Related Experiment Video
Updated: Jun 27, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Relapsing polychondritis: clinical updates and new differential diagnoses
Philippe Mertz1, Nathalie Costedoat-Chalumeau2, Marcela A Ferrada3
1Department of Rheumatology, National Reference Center for Rare Autoimmune Diseases (RESO), INSERM UMR-S 1109, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Relapsing polychondritis diagnosis is evolving with new patient clusters and emerging differential diagnoses like VEXAS syndrome. Early recognition of these distinct groups and mimickers improves patient management and prognosis.
Area of Science:
- Rheumatology
- Immunology
- Genetics
Background:
- Relapsing polychondritis (RP) is a rare systemic inflammatory condition affecting cartilaginous tissues.
- Accurate diagnosis of RP is critical for effective management and improved patient outcomes.
- Recent advancements have identified distinct RP patient clusters with varying clinical features and prognoses.
Purpose of the Study:
- To provide an updated review of relapsing polychondritis.
- To highlight newly identified patient clusters within RP.
- To discuss emerging differential diagnoses, including VEXAS syndrome and autoinflammatory diseases.
Main Methods:
- Review of recent literature on relapsing polychondritis.
- Analysis of newly identified patient clusters and their characteristics.
- Comparison with emerging differential diagnoses such as VEXAS syndrome.
Main Results:
- Identification of three distinct patient clusters in relapsing polychondritis.
- Emergence of new differential diagnoses, including vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome.
- Recognition of immune checkpoint inhibitor-related adverse events as potential mimics.
Conclusions:
- Understanding distinct RP clusters and mimickers significantly impacts clinical management.
- Prompt identification of red flags for alternative diagnoses is crucial.
- This knowledge improves follow-up and prognosis for patients with RP and related autoinflammatory syndromes.
More Related Videos
10:35Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Pneumonia III: Complications and Assessment